CBIS Stock | News | Quote | Stock Forum | Monday, February 10,

New Post Public Reply Private Reply Replies (0) Message Board

Feb 10, 2014 at 1:43 AM

$CBIS Cannabis Science, Inc. CBIS Company Overview

Cannabis Science, Inc. CBIS Current Price and Quotes
Last Price 0.222
Previous Close 0.2435 Open 0.2424
Daily Range 0.244 - 0.21 52wk Range 0.298 - 0.028
Volume 30,453,356 Dividend N/A
Average Vol (3m) 25,829,032 Yield N/A

CBIS Stock Message Board http://investorshangout.com/search?q=CBIS&...mp;yt1=Go!

Last Updated: Monday, February 10, 2014 01:42:56 AM

Cannabis Science, Inc. CBIS
Company Information

6946 N Academy Blvd
Suite B #254
Colorado Springs, CO 80918

Website: http://www.cannabisscience.com
Phone: 1 888 889 0888
Email: info@cannabisscience.com

Cannabis Science, Inc. CBIS
Research & Development of medical cannabis compounds

Cannabis Science, Inc. CBIS
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001024626
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 31, 2007
Incorporated In: NV, USA
Year of Inc. 1998
Employees 10 a/o Jun 17, 2010
Company Officers/Contacts

Dorothy Bray CEO
Robert Jean Melamede President, Interim CFO
Mark Friedman IR
Company Directors

Not Available
Company Notes

Formerly=Gulf Onshore, Inc. until 5-2009
Formerly=Brighton Oil & Gas, Inc. until 4-2008
Formerly=National Healthcare Technology, Inc. until 6-07. State of Incorporation Colorado changed to Nevada concurrent with name change
Service Providers

Auditor/Accountant
Turner, Stone & Company, L.L.P.
12700 Park Central Drive
Suite 1400
Dallas, TX, 75251
United States

Legal Counsel
Dean Law Corp.
601 Union St.
Seattle, WA, 98101
United States

Investor Relations Firm
Not Available

Cannabis Science, Inc. CBIS
CBIS Security Details

Share Structure

Market Value1 $169,013,907 a/o Feb 07, 2014
Shares Outstanding 761,323,906 a/o Nov 18, 2013
Float 24,000,000 a/o Jun 17, 2010
Authorized Shares 250,000,000 a/o Jun 17, 2010
Par Value 0.001
Shareholders

Shareholders of Record 467 a/o Apr 23, 2013
Security Notes

Capital Change=shs decreased by 1 for 100 split. Pay date=10-7-04.
Capital Change=shs decreased by 1 for 10 split. Pay date=12-12-07.
Capital Change=shs decreased by 1 for 10 split. Pay date=04/04/2008.
Short Selling Data

Short Interest 515,525 (91.39%)
Jan 15, 2014
Significant Failures to Deliver No
Transfer Agent(s)

Securities Transfer Corp

Cannabis Science, Inc. CBIS Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 37 74 4 -
Cost of Revenue - - - -
Gross Profit 37 74 4 -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 16,102 8,390 8,163 2,963
Non-Recurring Items 456 - - 1,459
Other 59 22 27 32
Operating Income (16,633) (8,338) (8,186) (4,453)
Income From Continuing Operations

Add'l Income/Expense Items 552 - 36 -
Earnings Before Interest and Tax (16,028) (8,338) (8,151) (4,532)
Interest Expense 9 1 3 -
Earnings Before Tax (16,037) (8,339) (8,154) (4,532)
Income Tax 1 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (16,038) (8,339) (8,154) (4,532)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (16,038) (8,339) (8,154) (4,532)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (16,038) (8,339) (8,154) (4,532)

Cannabis Science, Inc. CBIS Recent News

Feb 7, 2014 Former Microsoft Exec Predicts Hundreds of Marijuana Stores Open in 5 Years: Plandai Biotechnology's (OTCQB: PLPL), AVT Inc. (OTCPINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Cannabis Science Inc. (NASDAQ OTC: CBIS)
Feb 7, 2014 Unveiling of New Natural-Flavored e-Cigarette Ignites mCig's Stock Volume: mCig Inc. (OTCQB: MCIG), Growlife Inc. (OTCBB: PHOT), Cannabis Science Inc. (OTCQB: CBIS)
Feb 5, 2014 Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis
Feb 5, 2014 4 Marijuana Penny-Stocks Inch toward Becoming Players: Creative Edge Nutrition Inc.'s (OTC Pink: FITX), Growlife Inc. (OTCBB: PHOT), Cannabis Science Inc. (NASDAQ OTC: CBIS), Hemp Inc. (OTCPINK: HEMP)
Feb 4, 2014 Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law
Feb 3, 2014 4 Marijuana Stocks Built on Promising Practical Products: AVT Inc. (OTC PINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Medbox, Inc. (OTCPINK Markets: MDBX), Cannabis Science Inc. (NASDAQ OTC: CBIS)
Feb 3, 2014 CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements
Jan 30, 2014 Medical Marijuana Payment Provider Gets $1.1 Million from Unnamed Private-Equity Firm: MediSwipe Inc. (OTCQB: MWIP), Cannabis Science Inc. (NASDAQ OTC: CBIS), Medical Marijuana Inc. (OTC PINK: MJNA), Growlife Inc. (OTCBB: PHOT)
Jan 29, 2014 Cannabis Science (CBIS) Government Affairs Representative Lobbys' with the U.S. House of Representatives' Cannabis Caucus for President Obama to Join Congressional Cannabis Caucus in Ending Federal Restrictions on Cannabinoid Research
Jan 28, 2014 Greta Gaines Former Member of the National Board of the National Organization to Reform Marijuana Law (NORML) Joins Cannabis Science (CBIS) Team to Enhance Company's Business Development Activities

1
2
3
next >

CBIS Cannabis Science, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CBIS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CBIS/quote
Stock Chart http://www.otcmarkets.com/stock/CBIS/chart
Company Info http://www.otcmarkets.com/stock/CBIS/company-info
Recent News http://www.otcmarkets.com/stock/CBIS/news
Financials http://www.otcmarkets.com/stock/CBIS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CBIS/filings
Short Sales http://www.otcmarkets.com/stock/CBIS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CBIS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CBIS/research
Summary http://finance.yahoo.com/q?s=CBIS
Historical Prices http://finance.yahoo.com/q/hp?s=CBIS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CBIS
Basic Chart http://finance.yahoo.com/q/bc?s=CBIS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CBIS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CBIS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CBIS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CBIS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CBIS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CBIS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CBIS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CBIS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CBIS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CBIS
Balance Sheet http://finance.yahoo.com/q/bs?s=CBIS
Cash Flow http://finance.yahoo.com/q/cf?s=CBIS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CBIS
Market Watch http://www.marketwatch.com/investing/stock/CBIS
Bloomberg http://www.bloomberg.com/quote/CBIS:US
Morningstar http://quotes.morningstar.com/stock/s?t=CBIS
Bussinessweek http://investing.businessweek.com/research/st...icker=CBIS
Barchart http://www.barchart.com/quotes/stocks/CBIS
OTC Short Report http://otcshortreport.com/index.php?index=CBIS
Investopedia http://www.investopedia.com/markets/stocks/CBIS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Microsoft's Cloud Misstep: Recovery Plans in Focus

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Maritime Safety Urged After New Orleans Vessel Incident

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...